Literature DB >> 17914332

High-risk benign breast lesions: current strategies in management.

John V Kiluk1, Geza Acs, Susan J Hoover.   

Abstract

BACKGROUND: High-risk benign breast lesions can create confusion for both the patient and the clinician. This paper reviews the characteristics of these lesions to help direct appropriate management.
METHODS: The authors reviewed the literature regarding high-risk breast lesions and include management guidelines that we employ at our institute.
RESULTS: High-risk breast lesions offer varying degrees of increased risk for the future development of breast cancer. Chemoprevention may be used to help decrease the risks from some lesions.
CONCLUSIONS: The management of high-risk benign breast lesions can be confusing. Clinicians should assess the risk of future breast cancer and develop a proper screening and prevention strategy for each individual patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17914332     DOI: 10.1177/107327480701400402

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  5 in total

1.  Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.

Authors:  Safia Cheeney; Habib Rahbar; Brian N Dontchos; Sara H Javid; Mara H Rendi; Savannah C Partridge
Journal:  J Magn Reson Imaging       Date:  2017-02-09       Impact factor: 4.813

2.  Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.

Authors:  Diana S M Buist; Linn Abraham; Christoph I Lee; Janie M Lee; Constance Lehman; Ellen S O'Meara; Natasha K Stout; Louise M Henderson; Deirdre Hill; Karen J Wernli; Jennifer S Haas; Anna N A Tosteson; Karla Kerlikowske; Tracy Onega
Journal:  JAMA Intern Med       Date:  2018-04-01       Impact factor: 21.873

3.  Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade.

Authors:  Roberto Lo Gullo; Kerri Vincenti; Carolina Rossi Saccarelli; Peter Gibbs; Michael J Fox; Isaac Daimiel; Danny F Martinez; Maxine S Jochelson; Elizabeth A Morris; Jeffrey S Reiner; Katja Pinker
Journal:  Breast Cancer Res Treat       Date:  2021-01-20       Impact factor: 4.872

4.  Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening.

Authors:  Christiane K Kuhl; Annika Keulers; Kevin Strobel; Hannah Schneider; Nadine Gaisa; Simone Schrading
Journal:  Breast Cancer Res       Date:  2018-02-09       Impact factor: 6.466

5.  Diagnostic Value of Contrast-Enhanced Digital Mammography versus Contrast-Enhanced Magnetic Resonance Imaging for the Preoperative Evaluation of Breast Cancer.

Authors:  Eun Young Kim; Inyoung Youn; Kwan Ho Lee; Ji-Sup Yun; Yong Lai Park; Chan Heun Park; Juhee Moon; Seon Hyeong Choi; Yoon Jung Choi; Soo-Youn Ham; Shin Ho Kook
Journal:  J Breast Cancer       Date:  2018-12-26       Impact factor: 3.588

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.